[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Voyager Therapeut (VYGR)

Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 250,747
  • Shares Outstanding, K 60,421
  • Annual Sales, $ 40,370 K
  • Annual Income, $ -119,720 K
  • EBIT $ -97 M
  • EBITDA $ -131 M
  • 60-Month Beta 1.26
  • Price/Sales 6.21
  • Price/Cash Flow N/A
  • Price/Book 1.44

Options Overview Details

View History
  • Implied Volatility 278.68% (+73.99%)
  • Historical Volatility 46.42%
  • IV Percentile 42%
  • IV Rank 23.42%
  • IV High 1,136.62% on 01/06/26
  • IV Low 16.29% on 02/17/26
  • Expected Move (DTE 1) 0.30 (6.95%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 515
  • Volume Avg (30-Day) 824
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 4,532
  • Open Int (30-Day) 4,291
  • Expected Range 3.98 to 4.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.55
  • Number of Estimates 5
  • High Estimate $-0.28
  • Low Estimate $-0.72
  • Prior Year $-0.57
  • Growth Rate Est. (year over year) +3.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.63 +18.73%
on 04/29/26
4.45 -3.25%
on 05/14/26
+0.37 (+9.39%)
since 04/14/26
3-Month
3.26 +32.21%
on 02/19/26
5.48 -21.32%
on 03/11/26
+0.92 (+27.14%)
since 02/13/26
52-Week
2.64 +62.95%
on 05/30/25
5.55 -22.34%
on 10/16/25
+1.12 (+35.11%)
since 05/14/25

Most Recent Stories

More News
Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026

- VY1706 IND application process on track for Q2 2026; clinical entry expected H2 2026 - - Data from eight ASGCT presentations highlight Voyager’s continued innovation in gene therapy - LEXINGTON,...

VYGR : 4.30 (+3.61%)
Voyager Therapeutics: Q1 Earnings Snapshot

Voyager Therapeutics: Q1 Earnings Snapshot

VYGR : 4.30 (+3.61%)
Voyager Reports First Quarter 2026 Financial and Operating Results

- VY1706 and NBIB-‘233 completed IND-enabling GLP toxicology; clinical entry expected H2 2026 - - Multiple presentations at ASGCT 2026, including late breaker on VY1706 3-month GLP tox data - ...

VYGR : 4.30 (+3.61%)
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

- Late-breaking oral presentation: IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month GLP toxicology study in NHPs - - Additional...

VYGR : 4.30 (+3.61%)
Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Therapeutics: Q4 Earnings Snapshot

VYGR : 4.30 (+3.61%)
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

- Transformative year for tau in AD: VY1706 clinical entry and VY7523 clinical data anticipated H2 2026 -  - Validating brain-targeted capsids in humans: expect two I.V.-delivered neuro gene therapies...

VYGR : 4.30 (+3.61%)
Voyager to Present at Upcoming Investor Conferences

LEXINGTON, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced...

VYGR : 4.30 (+3.61%)
Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Therapeutics: Q3 Earnings Snapshot

VYGR : 4.30 (+3.61%)
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia

CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking traditionally “undruggable” targets by leveraging biomolecular...

VYGR : 4.30 (+3.61%)
Voyager Reports Third Quarter 2025 Financial and Operating Results

- Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 -  - Sharpened focus on multi-modality pipeline with introduction of Voyager NeuroShuttle™ discovery...

VYGR : 4.30 (+3.61%)

Business Summary

Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs...

See More

Key Turning Points

3rd Resistance Point 4.40
2nd Resistance Point 4.33
1st Resistance Point 4.24
Last Price 4.30
1st Support Level 4.08
2nd Support Level 4.01
3rd Support Level 3.92

See More

52-Week High 5.55
Fibonacci 61.8% 4.44
Last Price 4.30
Fibonacci 50% 4.10
Fibonacci 38.2% 3.75
52-Week Low 2.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.